| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |